Changes in radiation oncology infrastructure influence referral/practice patterns and resident educational experiences. This study aimed to analyze effects of closure of an academic proton treatment center (PTC) on pediatric case volume, distribution, and resident education. We demonstrate a sharp decrease in overall pediatric cases and potentially curable CNS tumors treated at our center following PTC closure. Our findings raise important questions regarding resident training in pediatric radiation oncology as these cases become concentrated at specialized centers. .010) and their radiation courses were longer (35.4 vs 20.9 days, p<0.0001) than those treated after its closure. Resident case logs showed only a small decline in total pediatric cases, as the percentage of pediatric cases covered by residents increased after PTC closure; however, residents logged fewer CNS cases after PTC closure vs. before.
Introduction
Approximately 12,000 children and adolescents are diagnosed with cancer annually in the US [1] , around 3,000 of whom receive radiation therapy (RT) [2] . Compared with photon RT (XRT), proton beam therapy (PBT) decreases dose to nearby organs at risk (OAR), reduces integral dose, and may reduce acute and late toxicities as well as secondary malignancies [3] . PBT has therefore gained increasing acceptance in the treatment of pediatric solid tumors [4] . In patients who require craniospinal irradiation (CSI), PBT can spare anterior OARs including the heart, lungs, esophagus, chest wall, gastrointestinal tract, and breasts [5, 6] . There is also sound rationale for PBT in the treatment of central nervous system (CNS) and ocular malignancies, given the risk of serious neurologic sequelae such as cognitive dysfunction and hearing loss in children who undergo brain irradiation [6] [7] [8] . PBT may also provide a dosimetric advantage in certain sarcomas, such as orbital and genitourinary rhabdomyosarcoma, mostly due to sparing of proximal OARs [9, 10] . The clinical advantages of PBT over XRT may decrease when low doses are administered, when large, nonconformal fields are treated, or in palliative cases [11] . Additionally, XRT remains standard for total body irradiation (TBI) before stem cell transplant. Nationwide, PBT utilization continues to rise, increasing by 33% for all pediatric cancers between 2010-2012 [12] . A recent National Cancer Database study reported that although <1% of children with CNS tumors received PBT in 2004, this had increased to 15% by 2012 [13] . As of this writing, there are 25 US proton treatment centers (PTC), up from 14 in 2014 [14, 15] . Our institution [17] It remains the only proton center associated with an academic health system to close without being replaced. We hypothesized that the closure of the PTC would be associated with significant alterations in the number and distribution of pediatric cases treated within our department and that the PTC closure might affect resident education in pediatric cancers. The goal of the present study was to quantify changes in pediatric case volume due to the PTC's closure and to describe how these changes affected resident training.
Methods

Program Setting, Patient Selection, and Data Reporting
This study was conducted at a single academic radiation oncology department with an ACGME-accredited radiation oncology residency program. At the time of this writing, the program had 8 residents and 9 full-time clinical faculty members. A single faculty member maintained a dedicated pediatric service while the proton center was open as well as during and after its closure.
Residents were periodically assigned to the PTC as a unified rotation but not specifically to the pediatric service. After the PTC closed, the resident rotation schedule was changed to its present structure, which ensures that a dedicated resident is assigned to the pediatric service.
After approval was obtained from our internal institutional review board, the electronic medical record was queried for all patients aged ≤18 years who received RT in our department between 1/1/2012-12/31/2016. Case volumes are reported over 6-month blocks before and after the PTC closure in order to minimize bias due to month-to-month variability in case loads for relatively rare diagnoses. Differences in patient volume, age, and treatment duration were analyzed PROTON CENTER CLOSURE AND PEDIATRIC CASE VOLUME 
Results
Patient Volume, Demographics, and Radiation Technique
During the study period, 412 radiation courses were delivered in 388 individual patients (Table 1) ; 199 and 213 courses were delivered with PBT and XRT, respectively. Fifty-one patients underwent CSI, 37 had TBI, and 7 underwent stereotactic radiosurgery (SRS), primarily for AVMs. XRT is less clear. With the decrease in definitive CNS cases, we observed a sharp decline in the number of CSI plans delivered in our department after the PTC closed, which may be due to several factors, including growing acceptance of PBT as the standard of care for pediatric patients who require CSI [18] . Additionally, since all pediatric solid tumor cases treated at our institution are discussed prior to treatment in multidisciplinary tumor boards, our pediatric radiation oncologists may suggest direct referral to a proton center (rather than consultation in our department) in order to expedite treatment. Our sarcoma case volume also declined, but to a lesser extent than CNS tumors. Sarcomas are heterogeneous in terms of both histology and anatomic site, and the PROTON CENTER CLOSURE AND PEDIATRIC CASE VOLUME 8 presumptive advantage of PBT varies. For example, the presumed benefit of PBT over XRT may be greater for a skull base chordoma than an extremity rhabdomyosarcoma [19] .
Unlike CNS tumors and sarcoma, case volumes for hematologic malignancies and non-CNS solid tumors remained relatively stable. These patients are typically treated with lower total doses and less conformal fields than CNS and head/neck tumors, reducing the expected benefit of PBT.
For example, patients with WT who require low-dose radiation to the flank, whole abdomen, whole lung, or liver would be anticipated to derive little additional clinical benefit from PBT [11] . Similar considerations apply to patients with HL and neuroblastoma.
We also observed that between 2012-2014, mean patient age was significantly lower, and the treatment duration was significantly longer, compared to 2015-2016. The age differential is likely due to the shift of diagnoses away from CNS tumors and towards lymphoma, as lymphomas tend to be more common in adolescents [1] . The shorter course length after the PTC closure is likely due partly to the decreasing number of CNS tumors, since many patients with CNS tumors receive 4-6 weeks of radiation compared to 2-4 weeks for patients with diagnoses such as WT and HL. Also, a greater proportion of patients may have been treated with palliative intent after 2015, although we were unable to collect specific data regarding treatment intent in this study. To better account for the shift in diagnoses from CNS to hematologic malignancies, course length for only non-CNS solid tumors (sarcoma, WT, and neuroblastoma) was analyzed. There was a similar decline in treatment duration in this cohort, suggesting more of these patients were treated palliatively.
The total number of pediatric cases logged by residents declined only slightly after the PTC closure, although the case logs still reflect a large decline in the pediatric CNS case volume treated in our department. This observation is likely due to factors specific to our cancer center. The PTC was located in [redacted], which is approximately 50 miles from our main cancer center in [redacted] .
PROTON CENTER CLOSURE AND PEDIATRIC CASE VOLUME 9 Although residents were periodically assigned to the PTC, the majority of cases treated there did not have resident involvement in the treatment planning process. In contrast, most academic PTCs are closer to the main teaching site [20] , which may result in residents being able to log a higher proportion of pediatric PBT patients. After the PTC closed, all pediatric patients have been treated at our main cancer center in [redacted], and we now mandate full-time resident coverage of the pediatric service. Both of these changes have allowed residents to log a higher proportion of pediatric cases. However, the relative stability in case numbers was a result of structural factors unique to our program, and our overall case volume does not appear to be an adequate metric for the distribution of cases available for resident education, since case volume remained the same while the number of definitive CNS cases available for resident education declined dramatically. This change could only be identified with a detailed review of our resident case logs. Similar to the overall departmental trend, resident case logs reflected the decreasing number of patients with CNS tumors The challenges of providing adequate training in pediatric radiation oncology have been well described and are related to low patient numbers, the concentration of pediatric cancer care within large specialized centers, and the complexity and diversity of pediatric cancers [21] [22] [23] . These issues are not unique to our institution; the limited availability of PBT has likely amplified the ongoing trend of concentrating pediatric radiation cases at specialized institutions [10] . Current ACGME requirements stipulate that all residents must plan at least twelve pediatric cases over a four-year residency. This requirement has remained unchanged in the face of an ever-increasing number of residency positions nationwide and longstanding evidence that the distribution of pediatric case volume is decidedly inhomogeneous and likely becoming more so [13, 22] . A 2013 paper estimated PROTON CENTER CLOSURE AND PEDIATRIC CASE VOLUME 10 that radiation oncology residents would be expected to see an average of 4.6 pediatric cases per year, assuming that all pediatric patients are treated at academic centers with radiation oncology residency programs and that pediatric case volume is distributed homogeneously among all centers (assumptions which are clearly incorrect) [22] . Since that paper was published, the number of radiation oncology residency positions has increased, with a total of 746 slots filled in the National Resident Matching Program in the past 4 years [24] . Assuming that total pediatric case volume has remained relatively constant over the past three years, the average number of pediatric cases per resident has decreased to 3.4 cases annually (or a total of 13.6 cases over the four-year residency).
Given these numbers, residents in programs that treat few children are almost certain to have to consider alternative opportunities, most likely away rotations, in order to fulfill their training requirements. Graduating residents are well aware of these challenges, with 49.3% of respondents in a recent survey reporting "no or inadequate level of exposure" to pediatric diseases [25] .
Furthermore, it remains unclear whether the graduation requirement for planning 12 pediatric cases confers true expertise in treating these cancers [23] . It is concerning that if the trends described in this report continue, most graduating residents at our institution are unlikely to treat patients with ependymoma, medulloblastoma, LGG, or ever set up CSI fields; however, they would still meet their pediatric case requirements for independent practice. It is logical to conclude that many programs without access to a PTC would face similar deficits in training, especially in the treatment of pediatric CNS malignancies.
Most critically, outcomes in childhood cancer appear to be optimized when treatment is offered at high-volume institutions [26, 27] . Specialized pediatric cancer centers offer expertise in the medical management of childhood cancers and access to clinical trials, as well as multidisciplinary care including pediatric-focused behavioral, rehabilitation, and psychosocial support services, all of which are unlikely to be available at cancer centers that primarily treat adult patients. Certainly the PROTON CENTER CLOSURE AND PEDIATRIC CASE VOLUME 11 pedagogical demands of radiation oncology residency training should not be prioritized over providing the best possible care to children with cancer. If the clear advantage of concentrating pediatric oncology care within specialized high-volume centers of excellence decreases the ability of some residency programs to provide adequate exposure to the full spectrum of pediatric cancers, how can we adjust resident training to compensate? One potential solution is additional subspecialty or fellowship training in pediatric radiation oncology. Unfortunately, experts in the field have assessed that American Board of Medical Specialties endorsement of pediatric radiation oncology fellowships is unlikely due to the small projected number of potential training programs and reluctance to shift the pediatric experience out of core radiation oncology training [22] . Two existing pediatric fellowships remain non-ACGME accredited given the above concerns [28] . Other options for enhancing resident education in pediatric oncology include improving access to elective rotations at high-volume pediatric centers or providing universal access to case simulations designed and evaluated by experts in pediatric oncology.
Our results are limited by the fact that this is a study of a unique experience (the closure without replacement of a large regional referral center for proton therapy), and it is unknown whether our experience can be extrapolated to other settings. Second, the decrease in pediatric volume was likely not solely due to the PTC's closure. When our center first began treating patients in 2004, it was the only proton center in the Midwest. However, over time, additional proton centers have opened in the Midwest, and at this writing, there are seven proton facilities within a 500-mile radius of our hospital (Figure 1) [15, 20, [29] [30] [31] [32] [33] [34] [35] . These additional centers may have decreased our patient volume regardless of the PTC's status.
Despite these limitations, our experience clearly demonstrates that pediatric case volume and distribution within an academic radiation oncology department will vary based on available PROTON CENTER CLOSURE AND PEDIATRIC CASE VOLUME 12 technology and referral base. PTC closure led to a large drop in the number of pediatric CNS cases treated in our department. This may have compromised resident education in pediatric malignancies, although our residents still fulfilled their required case numbers for graduation. Given the complexity of pediatric oncology, we agree that most children with cancer should be cared for at high volume centers [22] and recognize that this will limit the clinical experiences of residents at some training programs. Nonetheless, it is necessary to guarantee that all radiation oncology residents receive sufficient training in pediatric cancers in order to ensure that patients who cannot be treated at centers of excellence still receive adequate care.
Conclusions
The volume of pediatric cases treated at our institution decreased after the closure of a proton therapy center, with the most dramatic decline seen in CNS tumors. Although the total number of pediatric cases logged by residents remained relatively stable, the closure of the proton center resulted in a substantial reduction in our residents' clinical exposure to several fundamental pediatric cancers, most importantly CNS tumors such as ependymoma, LGG, and medulloblastoma.
Continued study is needed regarding how to fulfill the critical goals of optimizing pediatric radiation oncology care while providing adequate clinical training in the treatment of childhood cancers. 
